Skip to main content
Skip to main content
OSCR logo

Oscar Health, Inc. (OSCR) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$32.58 +$0.82 (+2.58%) |Exceptional · 95
Oscar Health, Inc. (OSCR) bottom line: Bullish Lean — our Council read (72/100) and AI Score (95/100) broadly agree. Strongest signal: Valuation strong · Biggest watch-out: Izzy Englander bearish.Educational signal, not a buy or sell recommendation. Compare sector peers → · Read the method →
MCap: $8.45B| P/E Ratio: 19.05| Vol: 4.11M| Target: $27.25 (-16.4%) (Aug 25, 2026) (estimate, not advice)| 52-wk range: $10.69 – $33.55

P/E 19.05 means the share price is 19.05 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $8.45B is the value of all shares combined. Beta 1.93: the stock has moved about 93% more than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 9, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Oscar Health, Inc. (OSCR) trades at $32.58 with MoonshotScore 95/100 (Grade A+). Oscar Health, Inc. is a technology-driven health insurance company offering a range of plans and services. Market cap: $8.45B, Sector: Healthcare.

Price as of Sep 11, 2026 · Last analyzed: May 9, 2026
Oscar Health, Inc. is a technology-driven health insurance company offering a range of plans and services. The company focuses on leveraging its technology platform to improve member engagement and healthcare outcomes.

OSCR stock analysis for 2026: Analysts have set a consensus price target of $27.25 for Oscar Health, Inc., suggesting 16.4% downside from the current price of $32.58. The AI MoonshotScore is 95/100, in the Exceptional band (80-100) — a research signal, not a recommendation. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the OSCR film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

Council Score · Weighted Average of 3 Disciplines
Bullish Lean 72/100 · A

OSCR: 1/3 scored disciplines lean bullish. Dominant signal: Valuation strong.

How is this calculated? →
MoonshotScore · Five-pillar engine · 95/100
Business Quality
Strong Is this a genuinely good business?
Financial Safety
Neutral Could this blow up on me?
Valuation
Strong Am I paying a fair price?
Growth Durability
Weak Is the growth real and likely to last?
Momentum
Strong Is the market already moving on this?

Strongest side: Valuation (10/10, Strong). Weakest side: Growth Durability (4/10, Weak).

Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Favorable read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Unfavorable read
Klarman-style lens (simulated)Seth Klarman
Favorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Moderate
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Oscar Health, Inc. (OSCR) Healthcare & Pipeline Overview

CEOMark Thomas Bertolini
Employees2,305
HeadquartersNew York City, NY, US
IPO Year2021

Oscar Health, Inc., founded in 2012, provides health insurance products and services in the United States, including Individual & Family, Small Group, and Medicare Advantage plans. The company differentiates itself through its technology-driven +Oscar platform, designed to enhance member engagement and streamline healthcare processes, operating in a competitive healthcare landscape.

Data Provenance | Financial Data Quantitative Analysis NYSE Analysis: May 9, 2026

What Is the Investment Thesis for OSCR?

AI-written as of May 9, 2026 — figures and tone reflect the data available then, not today's score.

The company's focus on leveraging technology to improve member engagement and streamline healthcare processes positions it favorably in a rapidly evolving industry. With a market capitalization of $8.45B, Oscar Health is navigating a competitive landscape. Key to its success will be continued growth in membership across its Individual & Family, Small Group, and Medicare Advantage plans. The +Oscar platform's ability to drive efficiency and improve health outcomes will be a critical value driver. However, the company's negative profit margin of -0.3% necessitates careful monitoring of its path to profitability. The high beta of 1.93 indicates significant volatility, requiring investors to consider the inherent risks associated with the stock.

Based on FMP financials and quantitative analysis

OSCR Key Highlights

AI-written as of May 9, 2026 — figures and tone reflect the data available then, not today's score.

Market Cap of $8.45B reflects investor valuation of Oscar Health's growth potential in the health insurance market.

  • Gross Margin of 17.4% indicates the profitability of Oscar Health's core insurance operations after accounting for direct costs.
  • Profit Margin of -0.3% highlights the company's current challenges in achieving overall profitability, requiring focus on cost management and revenue growth.
  • The company offers Individual & Family, Small Group, and Medicare Advantage plans, catering to diverse needs across different demographics.
  • Oscar Health's +Oscar platform differentiates the company through its technology-driven system designed to connect providers, payors, and members, facilitating seamless communication and personalized care.

Who Are OSCR's Competitors?

OSCR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
ACLX Arcellx, Inc. $115.07 +0.02% $6.73B
IMVT Immunovant, Inc. $38.10 -1.68% $7.86B
AKRO Akero Therapeutics, Inc. $54.65 0.00% $4.50B
ALHC Alignment Healthcare, Inc. $12.54 -1.69% $2.60B 845-pillar
NAMS NewAmsterdam Pharma Company N.V. $22.26 +1.82% $2.60B
MOH Molina Healthcare, Inc. $200.28 +3.17% $10.5B 715-pillar
CLOV Clover Health Investments, Corp. $4.71 +8.53% $2.44B 375-pillar
CNC Centene Corporation $65.40 +2.09% $32.3B 715-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are OSCR's Key Strengths?

Innovative technology platform (+Oscar).

  • Strong brand recognition among tech-savvy consumers.
  • Focus on member engagement and personalized care.
  • Growing market presence in select geographic areas.

What Are OSCR's Weaknesses?

Negative profit margin.

  • High beta indicates significant stock volatility.
  • Limited geographic reach compared to larger competitors.
  • Reliance on regulatory approvals and market conditions.

What Could Drive OSCR Stock Higher?

Continued growth in membership across Individual & Family, Small Group, and Medicare Advantage plans.

  • Expansion of the +Oscar platform's capabilities and features.
  • Potential partnerships with healthcare providers to expand network and improve care coordination.
  • Regulatory approvals for new plan offerings and geographic expansion.
  • Positive impact of data analytics on personalized care and health outcomes.

What Are the Key Risks for OSCR?

Negative return on equity (-3.3%) — the business is not currently generating profit on shareholder capital.

  • Insider selling — insiders were net sellers of roughly $101.0M recently.
  • Intense competition from established health insurance companies.
  • Increasing regulatory scrutiny and compliance requirements.
  • Rising healthcare costs and potential for adverse selection.
  • Economic downturn and potential impact on membership growth.
  • Cybersecurity threats and data breaches.

What Are the Growth Opportunities for OSCR?

  • Expansion of Medicare Advantage Plans: Oscar Health has the opportunity to expand its Medicare Advantage offerings to new geographic markets. The Medicare Advantage market is projected to continue growing as the senior population increases. By offering competitive plans with attractive benefits and leveraging its technology platform to enhance member experience, Oscar Health can capture a larger share of this market. Successful expansion requires navigating regulatory requirements and effectively managing healthcare costs.
  • Strategic Partnerships with Healthcare Providers: Forming strategic partnerships with healthcare providers can drive member acquisition and improve care coordination. By integrating its technology platform with provider systems, Oscar Health can facilitate seamless data exchange and improve communication between providers and members. This can lead to better health outcomes and increased member satisfaction. Successful partnerships require aligning incentives and establishing clear protocols for data sharing and care coordination.
  • Enhancement of the +Oscar Platform: Continued investment in and enhancement of the +Oscar platform can drive efficiency and improve member engagement. By adding new features and functionalities, such as telehealth services, remote monitoring, and personalized health recommendations, Oscar Health can differentiate itself from competitors and attract new members. The platform can also be leveraged to improve risk management and reduce healthcare costs. Ongoing development and maintenance of the platform are essential to maintaining its competitive advantage.
  • Geographic Expansion into Underserved Markets: Oscar Health can pursue geographic expansion into underserved markets where there is a lack of access to quality healthcare. By offering affordable and accessible health insurance plans, Oscar Health can address unmet needs and improve health outcomes in these communities. This requires careful market analysis and a tailored approach to plan design and delivery. Building trust and establishing strong relationships with local stakeholders are critical to success.
  • Leveraging Data Analytics for Personalized Care: Oscar Health can leverage data analytics to personalize care and improve health outcomes. By analyzing member data, Oscar Health can identify individuals at high risk for chronic conditions and proactively intervene to prevent disease progression. Personalized care plans can be developed based on individual needs and preferences, leading to better adherence and improved health outcomes. Ethical considerations and data privacy must be carefully addressed when using data analytics for personalized care.

What Are OSCR's Competitive Advantages?

  • Technology-driven platform (+Oscar) provides a competitive advantage in member engagement and care coordination.
  • Brand recognition as an innovative and user-friendly health insurance provider.
  • Data analytics capabilities enable personalized care and improved health outcomes.
  • Established relationships with healthcare providers and payors.

What Does OSCR Do?

Oscar Health, Inc., established in 2012, emerged with a vision to revolutionize the healthcare insurance landscape through technology. Recognizing the complexities and inefficiencies within the traditional healthcare system, the founders sought to create a user-friendly, transparent, and accessible insurance experience. Initially known as Mulberry Health Inc., the company rebranded as Oscar Health, Inc. in January 2021, solidifying its commitment to innovation. Oscar Health offers a variety of health insurance plans, including Individual & Family, Small Group, and Medicare Advantage, catering to diverse needs across different demographics. A key differentiator is its +Oscar platform, a technology-driven system designed to connect providers, payors, and members, facilitating seamless communication and personalized care. This platform aims to improve member engagement, streamline administrative processes, and ultimately drive better health outcomes. Headquartered in New York City, Oscar Health operates across multiple states in the United States, focusing on select markets with growth potential. The company also provides reinsurance products, further diversifying its revenue streams. Oscar Health competes with established players in the health insurance industry, emphasizing its technology-centric approach and member-focused services to gain market share.

What Products and Services Does OSCR Offer?

  • Provides Individual & Family health insurance plans.
  • Offers Small Group health insurance plans for businesses.
  • Administers Medicare Advantage plans for eligible individuals.
  • Operates the +Oscar technology platform to connect providers, payors, and members.
  • Offers reinsurance products to other insurance companies.
  • Focuses on improving member engagement through technology-driven solutions.
  • Aims to streamline healthcare processes and improve health outcomes.

How Does OSCR Make Money?

  • Generates revenue through premiums from health insurance plans.
  • Earns fees from reinsurance products.
  • Leverages technology to reduce administrative costs and improve efficiency.
  • Focuses on member acquisition and retention through competitive plan offerings and personalized services.

What Industry Does OSCR Operate In?

Oscar Health operates within the dynamic and highly competitive healthcare insurance industry. The industry is characterized by increasing regulatory scrutiny, evolving consumer expectations, and technological advancements. Market trends include a growing emphasis on value-based care, personalized medicine, and digital health solutions. Oscar Health's technology-driven approach aligns with these trends, positioning it to capitalize on the shift towards more efficient and patient-centric healthcare. Competitors such as Alignment Healthcare, Inc. (ALHC) also focus on specific segments like Medicare Advantage, while others like Arcellx, Inc. (ACLX), Immunovant, Inc. (IMVT), Akero Therapeutics, Inc. (AKRO), and NewAmsterdam Pharma Company N.V. (NAMS) operate in different areas of the healthcare sector.

Who Are OSCR's Key Customers?

  • Individuals and families seeking health insurance coverage.
  • Small businesses looking to provide health benefits to their employees.
  • Individuals eligible for Medicare Advantage plans.
  • Healthcare providers and payors utilizing the +Oscar platform.
  • Other insurance companies seeking reinsurance products.
Model self-rating on this text: 83% (not a measure of the evidence) Updated: May 9, 2026

Research confidence

High 100/100

Broad, current evidence sits behind this analysis.

  • Scored on 97% of our measures
  • Price is current
  • Latest filing 35 days ago
  • Covered by analysts

Why 95?

Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.

What is helping

  • +0.78 Gross profit per dollar of assets (Business Quality)
  • +0.61 Return on equity (Business Quality)
  • +0.54 Enterprise value vs free cash flow (Valuation)

What is holding it back

  • -0.48 5-year net income per share (Growth)
  • -0.35 Volatility vs the market (Financial Strength)
  • -0.33 Operating income growth (Growth)

Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 97
2026-08-26 97
2026-08-29 97
2026-09-01 91
2026-09-04 92
2026-09-07 94
2026-09-10 94

What changed?

The grade moved from 97 to 94 (-3).

What moved it up or down:

  • -20 Financial Safety
  • -2 Momentum
  • -1 Valuation

Held back by:

  • +4 Growth Durability

Over the same 18 days the stock moved -0.9%.

Net selling

Insider Activity

Over the past six months, Oscar Health, Inc. insiders filed 30 SEC Form 4 transactions — 22 sales and 8 purchases. On net that is roughly 2.6M shares disposed (about $101.0M), a signal worth weighing alongside the fundamentals.

Quarterly Financial Performance: Oscar Health, Inc.

Revenue for Oscar Health, Inc. came in at $4.88B during Q2 FY2026, a 5.0% improvement versus the preceding quarter. The company recorded net income of $361.8M, with diluted EPS of $1.09. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this mid-cap Healthcare company. Across the four most recent quarters, OSCR averaged $0.34 in diluted EPS.

OSCR Valuation & Market Position

With a $8.45B market cap, Oscar Health, Inc. sits in the mid-cap segment of the market. Analyst price targets span from $16.00 to $39.00, with a consensus of $27.25. At the current price of $32.58, that implies roughly 16% downside from the consensus target. Relative to its peer group, OSCR's quantitative score of 95/100 is above the peer average of 66/100.

ROE -3%

Key Financial Metrics

Return on equity for Oscar Health, Inc. stands at -3.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -0.4%, showing how much profit it generates from its asset base. Its free cash flow yield is 34.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.09 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -0.4%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 6/9

Financial Health

Oscar Health, Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.89 places it in the grey zone, a middle ground that warrants monitoring.

5/8 beats

Earnings Track Record

Oscar Health, Inc. has beaten Wall Street's EPS estimate in 5 of its last 8 reported quarters — more hits than misses. Reported results have landed about 25.3% above estimates on average.

Company Profile

Oscar Health, Inc. operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in New York City, US. The company is led by CEO Mark Thomas Bertolini. OSCR has traded publicly since 2021.

OSCR Financials

Fundamental Snapshot

Revenue Growth (FY)
+27.5%
Free Cash Flow Growth (FY)
+11.4%
P/E (TTM)
19.05
Return on Equity (TTM)
-3.3%
Current Ratio
1.1
EV/EBITDA (TTM)
201

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Innovative technology platform (+Oscar).
  • Strong brand recognition among tech-savvy consumers.
  • Focus on member engagement and personalized care.
  • Growing market presence in select geographic areas.

Bear Case

  • Negative profit margin.
  • High beta indicates significant stock volatility.
  • Limited geographic reach compared to larger competitors.
  • Reliance on regulatory approvals and market conditions.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 $4.88B $362M $1.09
Q1 FY2026 $4.65B $679M $2.06
Q4 FY2025 $2.81B -$353M -$1.24
Q3 FY2025 $2.99B -$137M -$0.53

Q2 FY2026 · filed 7 Aug 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

OSCR Latest News

OSCR Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for OSCR.

Price Targets

Low
$16.00
Consensus
$27.25
High
$39.00

Median: $28.50 (-16.4% from current price)

Source: FMP analyst consensus · as of Aug 25, 2026 · an estimate, not advice

OSCR MoonshotScore

95/100

What does this score mean?

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. OSCR scores 95/100 (Grade A+): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Latest Oscar Health, Inc. Analysis

Leadership: Mark Thomas Bertolini

CEO

Mark Thomas Bertolini is an accomplished executive with extensive experience in the healthcare industry. He previously served as the Chairman and CEO of Aetna, a leading health insurance company, where he led the company through a period of significant growth and transformation. Bertolini has a strong track record of driving innovation and improving healthcare outcomes. He is known for his strategic vision and his commitment to creating a more consumer-centric healthcare system.

Track Record: During his tenure as CEO of Aetna, Mark Bertolini oversaw the acquisition of CVS Health, a transformative deal that aimed to integrate healthcare delivery and insurance coverage. He also led Aetna's efforts to expand its presence in the Medicare and Medicaid markets. Under his leadership, Aetna focused on improving member engagement and promoting preventive care. Bertolini's strategic decisions have had a lasting impact on the healthcare industry.

What Investors Ask About Oscar Health, Inc. (OSCR) — Healthcare

What does the AI Score mean for OSCR?

OSCR holds an AI Score of 95/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Oscar Health, Inc. is a technology-driven health insurance company offering a range of plans and services.

Is OSCR a good stock?

Stock Expert AI does not rate OSCR buy, sell or hold. Oscar Health, Inc. carries a MoonshotScore of 95/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What does Oscar Health, Inc. do?

Oscar Health, Inc. is a health insurance company that provides a range of health plans and services in the United States.

How does Oscar Health, Inc. navigate regulatory approval processes?

As a health insurance provider, Oscar Health, Inc. is subject to extensive regulatory oversight at both the state and federal levels.

What are the key factors to evaluate for OSCR?

Oscar Health, Inc. (OSCR) holds a MoonshotScore of 95/100 (high). P/E: 19.05x vs the S&P 500's ~20-25x. Analysts target $27.25 (-16%). Not financial advice.

How frequently does OSCR data refresh on this page?

OSCR's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven OSCR's recent stock price performance?

Oscar Health, Inc. (OSCR) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative technology platform (+Oscar). See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider OSCR overvalued or undervalued right now?

Oscar Health, Inc. (OSCR) trades at 19.05x earnings. Analysts target $27.25 (-16%) — downside risk seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of OSCR?

Yes, most major brokerages offer fractional shares of Oscar Health, Inc. (OSCR) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated MoonshotScore as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on publicly available sources and may be subject to change.
  • Financial data is as of the latest available reporting period.
  • This is not investment advice. Please consult with a qualified financial advisor before making any investment decisions.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover